TABLE 1.

Characteristics of the study sample, American medical students, December 2020–January 2021, during the COVID‐19 pandemic (n = 960)

	%
Gender
Male (n = 377)	39.3
Female (n = 575)	59.9
Non‐binary (n = 8)	0.8
Ethnicity
White (n = 605)	63.0
Asian (n = 210)	21.9
Hispanic (n = 35)	3.6
Black (n = 24)	2.5
Native American, Alaskan Native, Native Hawaiian or Pacific Islander (n = 0)	0.0
Two or more (n = 52)	5.4
Other (n = 34)	3.5
Location since March 2020
Rural (n = 160)	18.9
Urban (n = 685)	81.1
Geographic region
West (n = 301)	31.4
Southeast (n = 214)	22.3
Northeast (n = 130)	13.5
Midwest (n = 128)	13.3
Southwest (n = 72)	7.5
Unreported (n = 115)	12.0
Medical school type
Allopathic (MD) (n = 306)	31.9
Osteopathic (DO) (n = 654)	68.1
Stage of training
Didactics (n = 605)	63.7
Clinicals (n = 345)	35.3
Personal COVID diagnosis (n = 80)	8.3
Loved one diagnosed with COVID (n = 581)	60.5
Know someone who died of COVID (n = 237)	24.7
Contact with COVID patients
Educational basis (n = 236)	24.6
Volunteer basis (n = 91)	9.5
No (n = 633)	65.9
Level of worry about contracting COVID
Not worried at all (n = 191)	19.9
Somewhat worried (n = 436)	45.4
Very worried (n = 333)	34.7
Probable case of depression (n = 241)	25.1
Probable case of anxiety (n = 388)	40.4
Burnout
Overload dimension (n = 150)	15.9
Lack of development dimension (n = 61)	6.5
Neglect dimension (n = 113)	12.0
Met criteria for any dimension (n = 201)	21.3
Thoughts of self‐harm or suicide since March 2020 (n = 68)	7.2
Started or increased substance use since March 2020 (n = 179)	19.0
Accessed mental health care resources
Never accessed (n = 451)	47.9
Accessed only prior to March 2020 (n = 192)	20.4
Accessed only after March 2020 (n = 110)	11.7
Accessed before and after March 2020 (n = 188)	20.0